Related Experiment Video
Updated: Mar 22, 2026

Simultaneous Measurement of Superoxide/Hydrogen Peroxide and NADH Production by Flavin-containing Mitochondrial Dehydrogenases
Published on: February 24, 2018
Diaphorase Coupling Protocols for Red-Shifting Dehydrogenase Assays
Mindy I Davis1, Min Shen1, Anton Simeonov1
1NCATS Chemical Genomics Center, National Center for Advancing Translational Sciences, National Institutes of Health , Rockville, Maryland.
Developing novel cancer therapeutics targeting dehydrogenases is crucial. This study presents a robust assay using diaphorase coupling to reduce compound interference, enabling high-throughput screening for this important enzyme class.
Area of Science:
- Biochemistry
- Enzymology
- Drug Discovery
Background:
- Dehydrogenases are critical targets for cancer therapeutics.
- NAD(P)H fluorescence overlaps with compound libraries, hindering assays.
- A red-shifted assay is needed to reduce interference.
Purpose of the Study:
- To develop miniaturized, robust 1,536-well assays for dehydrogenases.
- To couple dehydrogenases to diaphorase for reduced compound interference.
- To provide guidelines for high-throughput screening of dehydrogenases.
Main Methods:
- Coupling dehydrogenases (WT IDH1, mutant IDH1 R132H) to diaphorase.
- Utilizing resazurin to resorufin conversion for fluorescence detection.
- Implementing kinetic and endpoint modes for different dehydrogenase activities.
- Developing counterassays to detect compound interference.
Main Results:
- Established robust and miniaturized 1,536-well assays for IDH1 and IDH1 R132H.
- Demonstrated reduced spectral interference from compound libraries.
- Validated the coupling technique for both NAD(P)H-producing and consuming dehydrogenases.
- Developed counterassays for reliable interference detection.
Conclusions:
- The diaphorase coupling method provides a reliable strategy for high-throughput screening of dehydrogenases.
- This approach minimizes compound interference, enhancing assay accuracy.
- The developed protocols serve as a foundation for screening diverse dehydrogenases as cancer drug targets.
More Related Videos
10:24Defining Hsp33's Redox-regulated Chaperone Activity and Mapping Conformational Changes on Hsp33 Using Hydrogen-deuterium Exchange Mass Spectrometry
Published on: June 7, 2018
08:36Metabolic Mapping: Quantitative Enzyme Cytochemistry and Histochemistry to Determine the Activity of Dehydrogenases in Cells and Tissues
Published on: May 26, 2018